Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
Nita Radhakrishnan, Additional Professor and HOD, Department of Pediatric Hematology-Oncology, shared on LinkedIn:
”Recent publication from our center adds real-world data on the clinical spectrum and outcomes of congenital afibrinogenemia, highlighting severe bleeding risks, diagnostic delays, and ongoing health-system challenges— in resource-limited settings.
Strengthens the case for improved recognition, registries, and access to fibrinogen replacement therapy.”
Read the full article here.
Article: Clinical outcomes and health-system challenges in congenital afibrinogenemia: a single-centre prospective case series
Authors: Nita Radhakrishnan, Savitri Singh, Archit Pandharipande, Eby P. Baby, Hari Gaire
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight
-
Aug 14, 2026, 18:20Venkata Sagi: Systemic Anticoagulation or Left Atrial Appendage Closure?
-
Aug 14, 2026, 18:02Marios Psychogios: Every Minute Matters in Acute Stroke Care
-
Aug 14, 2026, 17:57Molly Lippold-Meinholz: The Magic of Camp for Kids With Bleeding Disorders
-
Aug 14, 2026, 17:52Will Thomas: Why Dose Every Missed Thromboprophylaxis Matter
-
Aug 14, 2026, 17:42Nandini Pethe: Representing MicroHealth at BDC
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration